Skip to main content
PGEN logo
PGEN
(NASDAQ)
Precigen, Inc.
$3.94-- (--)
Loading... - Market loading

Precigen (PGEN) Stock Price & Financial Analysis

Precigen Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.75 - $4.03
52-Week High$5.47
52-Week Low$1.11
Open$3.86
Volume5.45M
Average Volume (3M)5.45M
Market Cap1.21B
Shares Outstanding307.17M
Price to Sales (P/S)191.34
Price to Book (P/B)28.83
EV/EBITDA-5.29
Revenue (TTM)6.31M
Net Income (TTM)-246.87M
Free Cash Flow (TTM)-75.62M
EPS (TTM)$-0.80
Profit Margin-3912.92%
Operating Margin-1706.63%
Return on Equity (ROE)-589.63%
Debt to Equity2.25
50-Day MA$4.03
200-Day MA$3.49
52-Week Change173.87%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Precigen

What is the current stock price for PGEN?

As of the latest trading session, PGEN stock trades at $3.94. The 52-week range is $1.11–$5.47, with a day range of $3.75–$4.03.

What is the P/E ratio for PGEN?

The P/E ratio (Price-to-Earnings) for PGEN is shown in the Key Statistics section. This valuation metric helps compare Precigen, Inc. to industry peers.

Does PGEN pay dividends?

Precigen does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PGEN?

Based on 2 analysts, the consensus for PGEN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of PGEN?

Precigen's market capitalization is $1.21B, classifying it as a small-cap company. Precigen operates in the Healthcare sector within the Biotechnology industry.